|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 84.5 TWD | +1.32% |
|
+0.84% | +4.97% |
| 21/05 | Ch Biotech R&D Co., Ltd. Approves the Appointments of the 4th Remuneration Committee Members | CI |
| 21/05 | CH Biotech R&D Co., Ltd. Announces Audit Committee Changes | CI |
CH Biotech R&D Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 1,018.51 million compared to TWD 702.19 million a year ago. Net income was TWD 291.5 million compared to TWD 100.16 million a year ago.
Basic earnings per share from continuing operations was TWD 3 compared to TWD 1.0348 a year ago. Diluted earnings per share from continuing operations was TWD 2.9652 compared to TWD 1.0261 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +4.97% | 265M | |
| -.--% | 11.49B | |
| -11.26% | 6.84B | |
| +3.62% | 6.61B | |
| -3.21% | 6.04B | |
| -10.07% | 5.72B | |
| -12.16% | 5.24B | |
| +28.40% | 5.06B | |
| -6.02% | 4.96B | |
| +4.86% | 3.91B |
CH BIOTECH R&D CO., LTD. 
